Report Detail

Request for Sample of this report

Pharma & Healthcare Global Plasma Albumin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4744909
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Plasma Albumin market size was valued at US$ 6414 million in 2025 and is forecast to a readjusted size of US$ 10310 million by 2032 with a CAGR of 7.1% during review period.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The plasma albumin market is primarily driven by the increasing demand for albumin in various medical applications. Albumin, a crucial protein found in blood plasma, plays a vital role in maintaining osmotic pressure, transporting nutrients, and regulating pH levels. As a result, it finds extensive use in therapeutic treatments for conditions like hypovolemia, burns, liver cirrhosis, and septic shock. Additionally, the rising prevalence of chronic diseases and surgical procedures further fuels the demand for albumin as a vital component in various medical products and therapies.However, the market also faces challenges, such as the limited availability of human plasma-derived albumin and the strict regulatory guidelines for its collection and purification. Ensuring a stable and adequate supply of albumin can be challenging, especially during times of high demand or unforeseen events. Moreover, the development of alternative albumin sources, such as recombinant human albumin, presents both opportunities and challenges for the market. Overcoming these obstacles through advanced production methods, research, and collaboration within the healthcare industry will be essential in meeting the growing demand and maintaining a sustainable plasma albumin market.
This report is a detailed and comprehensive analysis for global Plasma Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plasma Albumin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plasma Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plasma Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plasma Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plasma Albumin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plasma Albumin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Biotest, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Plasma Albumin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20-25% Concentrations
5% Concentrations
Market segment by Application
Therapeutics
Excipient
Other
Major players covered
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma Albumin, with price, sales quantity, revenue, and global market share of Plasma Albumin from 2021 to 2026.
Chapter 3, the Plasma Albumin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Plasma Albumin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma Albumin.
Chapter 14 and 15, to describe Plasma Albumin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Plasma Albumin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 20-25% Concentrations
    • 1.3.3 5% Concentrations
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Plasma Albumin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Therapeutics
    • 1.4.3 Excipient
    • 1.4.4 Other
  • 1.5 Global Plasma Albumin Market Size & Forecast
    • 1.5.1 Global Plasma Albumin Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Plasma Albumin Sales Quantity (2021-2032)
    • 1.5.3 Global Plasma Albumin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Grifols
    • 2.1.1 Grifols Details
    • 2.1.2 Grifols Major Business
    • 2.1.3 Grifols Plasma Albumin Product and Services
    • 2.1.4 Grifols Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Grifols Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Plasma Albumin Product and Services
    • 2.2.4 CSL Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 Takeda
    • 2.3.1 Takeda Details
    • 2.3.2 Takeda Major Business
    • 2.3.3 Takeda Plasma Albumin Product and Services
    • 2.3.4 Takeda Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Takeda Recent Developments/Updates
  • 2.4 Octapharma
    • 2.4.1 Octapharma Details
    • 2.4.2 Octapharma Major Business
    • 2.4.3 Octapharma Plasma Albumin Product and Services
    • 2.4.4 Octapharma Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Octapharma Recent Developments/Updates
  • 2.5 CBPO
    • 2.5.1 CBPO Details
    • 2.5.2 CBPO Major Business
    • 2.5.3 CBPO Plasma Albumin Product and Services
    • 2.5.4 CBPO Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CBPO Recent Developments/Updates
  • 2.6 Hualan Bio
    • 2.6.1 Hualan Bio Details
    • 2.6.2 Hualan Bio Major Business
    • 2.6.3 Hualan Bio Plasma Albumin Product and Services
    • 2.6.4 Hualan Bio Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hualan Bio Recent Developments/Updates
  • 2.7 Kedrion
    • 2.7.1 Kedrion Details
    • 2.7.2 Kedrion Major Business
    • 2.7.3 Kedrion Plasma Albumin Product and Services
    • 2.7.4 Kedrion Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Kedrion Recent Developments/Updates
  • 2.8 Shanghai RAAS
    • 2.8.1 Shanghai RAAS Details
    • 2.8.2 Shanghai RAAS Major Business
    • 2.8.3 Shanghai RAAS Plasma Albumin Product and Services
    • 2.8.4 Shanghai RAAS Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shanghai RAAS Recent Developments/Updates
  • 2.9 LFB Group
    • 2.9.1 LFB Group Details
    • 2.9.2 LFB Group Major Business
    • 2.9.3 LFB Group Plasma Albumin Product and Services
    • 2.9.4 LFB Group Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 LFB Group Recent Developments/Updates
  • 2.10 Biotest
    • 2.10.1 Biotest Details
    • 2.10.2 Biotest Major Business
    • 2.10.3 Biotest Plasma Albumin Product and Services
    • 2.10.4 Biotest Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Biotest Recent Developments/Updates
  • 2.11 Tiantan Bio
    • 2.11.1 Tiantan Bio Details
    • 2.11.2 Tiantan Bio Major Business
    • 2.11.3 Tiantan Bio Plasma Albumin Product and Services
    • 2.11.4 Tiantan Bio Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Tiantan Bio Recent Developments/Updates
  • 2.12 Shuanglin Bio
    • 2.12.1 Shuanglin Bio Details
    • 2.12.2 Shuanglin Bio Major Business
    • 2.12.3 Shuanglin Bio Plasma Albumin Product and Services
    • 2.12.4 Shuanglin Bio Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shuanglin Bio Recent Developments/Updates
  • 2.13 Boya Bio
    • 2.13.1 Boya Bio Details
    • 2.13.2 Boya Bio Major Business
    • 2.13.3 Boya Bio Plasma Albumin Product and Services
    • 2.13.4 Boya Bio Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Boya Bio Recent Developments/Updates
  • 2.14 Yuanda Shuyang
    • 2.14.1 Yuanda Shuyang Details
    • 2.14.2 Yuanda Shuyang Major Business
    • 2.14.3 Yuanda Shuyang Plasma Albumin Product and Services
    • 2.14.4 Yuanda Shuyang Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Yuanda Shuyang Recent Developments/Updates
  • 2.15 Weiguang Bio
    • 2.15.1 Weiguang Bio Details
    • 2.15.2 Weiguang Bio Major Business
    • 2.15.3 Weiguang Bio Plasma Albumin Product and Services
    • 2.15.4 Weiguang Bio Plasma Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Weiguang Bio Recent Developments/Updates

3 Competitive Environment: Plasma Albumin by Manufacturer

  • 3.1 Global Plasma Albumin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Plasma Albumin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Plasma Albumin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Plasma Albumin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Plasma Albumin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Plasma Albumin Manufacturer Market Share in 2025
  • 3.5 Plasma Albumin Market: Overall Company Footprint Analysis
    • 3.5.1 Plasma Albumin Market: Region Footprint
    • 3.5.2 Plasma Albumin Market: Company Product Type Footprint
    • 3.5.3 Plasma Albumin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Plasma Albumin Market Size by Region
    • 4.1.1 Global Plasma Albumin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Plasma Albumin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Plasma Albumin Average Price by Region (2021-2032)
  • 4.2 North America Plasma Albumin Consumption Value (2021-2032)
  • 4.3 Europe Plasma Albumin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Plasma Albumin Consumption Value (2021-2032)
  • 4.5 South America Plasma Albumin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Plasma Albumin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Plasma Albumin Sales Quantity by Type (2021-2032)
  • 5.2 Global Plasma Albumin Consumption Value by Type (2021-2032)
  • 5.3 Global Plasma Albumin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Plasma Albumin Sales Quantity by Application (2021-2032)
  • 6.2 Global Plasma Albumin Consumption Value by Application (2021-2032)
  • 6.3 Global Plasma Albumin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Plasma Albumin Sales Quantity by Type (2021-2032)
  • 7.2 North America Plasma Albumin Sales Quantity by Application (2021-2032)
  • 7.3 North America Plasma Albumin Market Size by Country
    • 7.3.1 North America Plasma Albumin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Plasma Albumin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Plasma Albumin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Plasma Albumin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Plasma Albumin Market Size by Country
    • 8.3.1 Europe Plasma Albumin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Plasma Albumin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Plasma Albumin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Plasma Albumin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Plasma Albumin Market Size by Region
    • 9.3.1 Asia-Pacific Plasma Albumin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Plasma Albumin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Plasma Albumin Sales Quantity by Type (2021-2032)
  • 10.2 South America Plasma Albumin Sales Quantity by Application (2021-2032)
  • 10.3 South America Plasma Albumin Market Size by Country
    • 10.3.1 South America Plasma Albumin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Plasma Albumin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Plasma Albumin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Plasma Albumin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Plasma Albumin Market Size by Country
    • 11.3.1 Middle East & Africa Plasma Albumin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Plasma Albumin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Plasma Albumin Market Drivers
  • 12.2 Plasma Albumin Market Restraints
  • 12.3 Plasma Albumin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Plasma Albumin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Plasma Albumin
  • 13.3 Plasma Albumin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Plasma Albumin Typical Distributors
  • 14.3 Plasma Albumin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Plasma Albumin. Industry analysis & Market Report on Plasma Albumin is a syndicated market report, published as Global Plasma Albumin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Plasma Albumin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo